via Harvard University
New test by ARU professor could cut false negatives and deliver faster results
Results of a unique test developed by a world-renowned expert, which targets three viral genes to increase reliability and could cut COVID-19 detection time to 20 minutes, have been peer reviewed and published in the journal Scientific Reports.
Stephen Bustin, Professor of Molecular Medicine at ARU and a leading expert in quantitative polymerase chain reaction (qPCR), which is widely used to detect infectious SARS-CoV-2 in cells, has developed the assay, called Cov2-ID, with colleagues at Broomfield Hospital in Chelmsford.
The test detects three viral targets, making it more reliable than other current tests to identify the virus which target one or two, and was 100% accurate in almost 30 patient samples taken. The test also has the potential to detect viral load, which is the amount of the virus present in each patient.
While most of the samples were taken in Essex and contained the mutant genotype of the virus, a sample taken from Australia contained a different “wild type” genotype.
Cov2-ID has been developed using MIQE guidelines, which were developed by Professor Bustin in collaboration with scientists across the world to promote best practice for qPCR assay design and publication, to produce results which are robust, sensitive and fast. It is also designed to minimise the likelihood of a false negative result which may lead to patients unwittingly infecting others.
The qPCR tests currently in use in the UK typically return results within between one and two hours. The Cov2-ID testing process is both faster and simple to carry out, and could potentially return results while the person tested waits, helping to reduce the spread of infection.
Professor Bustin said:
“Speed and reliability are vital elements of the testing process. Currently, it is not really feasible for someone to wait where they are for the results of their test. They might go to the shops, have some lunch, and only then get a positive result, risking community spread of the virus. We have developed a test that can deliver a result in just 20 minutes.
“Targeting three viral genes is unique, with most real-time qPCR assays currently only targeting two, This has led to some reports of false negative rates, again risking community spread. Our assay returned 100% accurate results from the samples collected.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- President Joe Biden tests negative for COVID-19
US President Joe Biden has tested negative for COVID-19, a week after he was revealed to have contracted a rare "rebound" case of the virus.
- Biden tests negative for COVID, but stays in isolation until 2nd test can confirm result
The president's doctor says that Biden is now negative for COVID-19, but that he'll keep isolating at the White House until he tests negative again.
- Biden tests negative for COVID-19, will continue isolation until second negative test
President Biden has tested negative for COVID-19 and will isolate at the White House until a second negative test, his doctor said Saturday.
- Biden tests negative for COVID-19, will remain in isolation pending second test
President Biden tested negative for COVID-19 on Saturday after battling a rebound case of the disease, but he will remain in self-imposed isolation pending a second negative test out of “an abundance ...
- Biden tests negative for COVID-19 but will continue isolation, pending a second negative test
Biden has been isolated in the White House since last Saturday after experiencing a rebound case of COVID-19 tied to his use of Paxlovid.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- COVID-19 Activities
The purpose of this trial is to evaluate treatment with IV-administered REGN-COV2, a combination therapy with two antibodies ... a sero-epidemiology study of SARS-CoV-2 in Blaine County, ID, with ...
- COVID-19 Diagnostic Kits Market Latest Trends, Size, Key Players, Revenue and Forecast 2028
For the past few years, COVID-19 has shown to be a threat to human civilisation. Industries have been devastated, ...
- Three doses of Novavax vaccine effective against Omicron subvariants
A recent article published on the bioRxiv* preprint server reports that the coronavirus disease 2019 (COVID-19) NVX-CoV2373 vaccine triggers robust neutralization against the severe acute ...
- Sanitizer Bottles Market to Receive Overwhelming Hike in Revenues By 2031 | TMR Study
flag=B&rep_id=82292 The majority of the sanitizer bottle ... Recently, an outbreak of the SARS-CoV2 has led the sanitizer bottle manufacturing companies to exceed the production beyond capacity ...
- L.A.’s New Universal Indoor Mask Mandate Would Include Restaurants, Retail, Gyms And Indoor Events
“I recognize that when we return to indoor masking this will seem like a step backwards,” Ferrer acknowledged. “The reality is that we’re living with a mutating SARS-CoV2 virus.” ...